This site has been created for exclusive use by institutional investors only and does not take into account investment objectives, financial situation or specific needs of any individual investor. Information should not be the sole basis for any investment decision.
If you are not an institutional client, consultant or financial professional and are looking for more information about mutual funds and other products at Nuveen, please visit our site at www.nuveen.com.
Past performance is not a guarantee of future performance. All investments involve some degree of risk including loss of principal. Investment objectives may not be met.
By agreeing you are confirming you are being truthful, acknowledging you have read the information above and accept the terms and conditions set out with this site and meeting the intended audience requirement for this site. Not all content on this site is appropriate or applicable for the general public and we cannot guarantee consequences with the use of this information by unauthorized or unintended users. Content on this site may not be redistributed and is for informational purposes only and does not constitute investment advice or provide a solicitation of an offer to buy any security.
The big bounce back
A high-velocity vaccine rollout, $1.9 trillion stimulus package and a year of pent-up consumerism mean the future is bright for U.S. mid-market direct lending, says Churchill Asset Management’s Randy Schwimmer.
Q: It has been a brutal 12 months, with many predicting a severe downturn. What are you seeing in terms of the wider economic backdrop to 2021?
At the end of last year, before vaccines began rolling out in the U.S. and with infections on the upswing, the mood was pessimistic. At that point many expected the recovery to be slow. Today public markets are reacting extremely favorably to improved vaccine distribution, the recently passed $1.9 trillion stimulus package and pent-up consumerism. That optimism is also reflected in the rise of long-term interest rates, with the 10-year treasury going from one percent to 1.6 percent in a matter of weeks. There’s a clear belief we will be coming out of this downturn sooner and more energetically that anticipated. Analysts are increasing their U.S. GDP forecasts; for example, Goldman Sachs expects almost 7 percent growth this year.
Q: How have different sectors of the economy been affected, and how is that translating into both portfolio health and new dealflow?
We break industries down into the haves and have-nots. The haves are companies either unaffected by or benefiting from the pandemic. Those companies operate in business-to-business industries such as healthcare, software, business services, technology and specialty manufacturing. Some pockets of retail have also fared well; shopping online, for example, or anything related to home improvement. The have-nots generally come from more consumer-facing parts of the economy – healthcare that requires in-person contact with the patient, fitness centers, leisure, hospitality and travel.
Churchill and other private debt lenders historically avoid the more cyclical industries – including real estate, chemicals and energy. That defensive posture has helped us weather past business cycles successfully. Because our portfolio had no COVID-related defaults we were able to pivot back to new business opportunities from the middle of last year on.
Our dealflow is driven by private equity sponsors with whom we have deep seated relationships. The tempo accelerated towards year-end as founders and CEOs looked to sell their companies before potentially higher capital gains taxes in a new administration.
Q: What are you seeing in terms of competition for those “haves” and what impact is that having on leverage profiles?
Purchase price multiples for COVID winners are higher than pre-COVID levels. If a business performed through the worst downturn in a century then it should do pretty well in normal times. Higher valuations have helped lenders as well. As sponsors put more cash into middle market buyouts, the ratio of equity to total capital has risen, now almost 60 percent. That’s a record high. So, although debt to EBITDA multiples are returning to pre-COVID levels, there’s more cushion for senior and junior debt. We see that trend continuing this year.
Purchase price multiples for COVID winners are higher than pre-COVID levels
Q: Where in the capital structure do you choose to play?
Churchill’s private capital strategy has four components: senior debt, junior debt, equity co-investments and private equity fund-of-fund investments. For most of the past 12 months, we have seen strong dealflow across all these disciplines. Our appetite is very deal-specific; each company presents a different growth and risk profile. Some have more steady, stable cashflows that are more attractive from a senior perspective. Others demonstrate higher growth potential, which aligns well with junior capital and equity. In some cases, the borrower exhibits both consistent cashflows and excellent upside, where it makes sense to participate up and down the capital structure.
Q: Do you expect to see any change to the direct-lending landscape in the coming months and years as a result of the pandemic?
The biggest change was the shrinking of the number of go-to arrangers sponsors tapped to lead deals in the second half of 2020. Some of that related to COVID’s impact on some lender portfolios. Managers with troubled credits hit the risk-off switch. We saw only a handful of competitors around processes.
Scale and relationships were also behind this trend; amid last year’s volatility sponsors needed to de-risk their financings. Increasingly competitive auctions compelled buyers to rely on lenders able to quickly commit and hold large dollars. Close familiarity with their PE clients allowed select credit providers to more efficiently negotiate documentation and to understand how to conform terms with the sponsors’ strategies.
Churchill has both scale and relationships, being an LP in funds of almost three-quarters of our priority sponsors. Getting the first (and often last) look at deals positioned us to frequently be working on multiple deals with the same client. That was certainly true at year-end. Incredibly, we closed almost 50 transactions, including add-ons, in the fourth quarter alone.
Q: Do you think there are any lessons that the private debt industry will take from the COVID crisis?
Liquidity is king. With consumers stuck at home last March revenues of certain borrowers were slashed. Those companies needed cash to survive – revolving credit facilities and/or equity injected by the sponsor. Direct lenders, and we were no exception, quickly engaged with clients to work through short-term cash needs. We then focused on their longer-term strategies, including expense reductions and credit agreement modifications, to help get to the other side of the pandemic.
That was the second important lesson: having an experienced private equity owner with deep pockets is critical to protecting enterprise value, and therefore a lender’s position, during times of stress. COVID was a perfect test of that thesis. Ensuring the sponsor’s investment strategy is aligned with the lender’s – and that lenders in the lender group are working together – resulted in successful outcomes.
Finally, the value of a consistent defensive investment strategy has also become apparent. Those of us who historically stayed away from cyclical industries or more consumer-sensitive sectors were the clear winners last year and will be in the future. Not having to change strategies meant experienced industry players came through COVID largely unscathed.
Private debt, which emerged from the GFC as an attractive asset class for investors seeking yield, conservative structures, and low volatility, has truly come of age during COVID.